Non-Eosinophilic Biological Effects of IL-5

Lung Fluid and Peripheral Blood Neutrophil IL-5 Surface Receptor in Children With Asthma

NCT02866487 ·Status: COMPLETED

Effects of Anti-IL5 Biological Treatments on Blood IgE Levels in Severe Asthmatic Patients

NCT04181190 ·Status: COMPLETED

Pilot Study to Identify the Mediators and Inflammatory Cell Surface Receptors Involved in Allergic Airway Inflammation

NCT00595491 ·Status: RECRUITING ·Phase: PHASE1

A Study to Evaluate the Safety, Tolerability and Effects of MEDI-563 in Adults With Asthma

NCT00659659 ·Status: COMPLETED ·Phase: PHASE1

An Investigation of Tumor Necrosis Factor (TNF)-Alpha in Asthma Using Biopsy Explants and Primary Bronchial Epithelial Cell Cultures

NCT01161303 ·Status: COMPLETED

The Prednisone-sparing Effect of Anti-IL-5 Antibody (SB-240563)

NCT00292877 ·Status: COMPLETED ·Phase: PHASE2

Characterization of Natural Killer Cells in Severe Asthma Patients in Comparison With Control Subjects

NCT06015256 ·Status: RECRUITING ·Phase: NA

Flow Cytometry Analysis of Eosinophils in Severe Asthma Patients.

NCT05001529 ·Status: UNKNOWN ·Phase: PHASE4

Study Evaluating the Effect of IMA-026 on Allergen-Induced Late Asthma Response in Mild Asthma

NCT00725582 ·Status: COMPLETED ·Phase: PHASE1

Using the Blood Eosinophil Count to Guide Systemic Corticosteroid Treatment in Asthma Exacerbations

NCT05417906 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study to Evaluate the Safety and Tolerability of the Administration of MEDI-528 When Administered in Multiple Doses to Adults With Mild Persistent Asthma

NCT00507130 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety Study of Reslizumab to Treat Poorly Controlled Asthma

NCT00587288 ·Status: COMPLETED ·Phase: PHASE2

A Phase II Study of 610 in Participants With Severe Eosinophilic Asthma

NCT05528679 ·Status: UNKNOWN ·Phase: PHASE2

Inflammation Following Mepolizumab and Oral Corticosteroids in Asthma

NCT03610685 ·Status: COMPLETED ·Phase: PHASE4

Effect of Benralizumab on Airway Remodeling in Asthma

NCT04365205 ·Status: RECRUITING

Control of Asthma Patients Symptomatic on Inhaled Corticosteroids

NCT00330070 ·Status: COMPLETED ·Phase: PHASE2

Effect of Anti-interleukin 5 (IL5) Therapy on Sputum Cells and Cytokines

NCT04412044 ·Status: COMPLETED ·Phase: PHASE4

A Phase 2a Study to Evaluate the Safety and Tolerability of Benralizumab (MEDI-563) in Adults With Asthma

NCT00783289 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Effect of Omalizumab on Improving the Tolerability of Specific Immunotherapy in Patients With Persistent Allergic Asthma

NCT00267202 ·Status: COMPLETED ·Phase: PHASE4

The Effect of BIIL 284 BS on Induced-sputum Variables in Patients With Bronchial Asthma

NCT02249312 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy Study of Omalizumab to Treat Allergic Asthma

NCT01976208 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

A Sequential Dose-Escalation Study in Subjects With Mild Asthma

NCT00512486 ·Status: COMPLETED ·Phase: PHASE1

Mechanisms of Acute Asthma Exacerbations Through Molecular Analysis of Airway Secretions and Tissues

NCT00603629 ·Status: COMPLETED

Airway Inflammation and Bronchial Hyperresponsiveness in Rhinitic Children With or Without Asthma

NCT02360072 ·Status: COMPLETED

Study to Evaluate the Inflammatory Cells Activity in Patients With Persistent Asthma Treated With Montelukast (0476-403)(COMPLETED)

NCT00770900 ·Status: COMPLETED ·Phase: PHASE4